TY - JOUR AU - Gupta, Shashi Prakash AU - D B, Vaghela PY - 2021/12/31 Y2 - 2024/03/28 TI - Management of Vataja abhishyanda (Allergic conjunctivitis) with Gutika anjana and Punarnavadi eye drops: A comparative clinical study JF - International Journal of Ayurvedic Medicine JA - IJAM VL - 12 IS - 4 SE - Research Articles DO - 10.47552/ijam.v12i4.2238 UR - https://ijam.co.in/index.php/ijam/article/view/2238 SP - 842-849 AB - <p>Background: <em>Vataja</em> <em>Abhishyanda</em> is characterized by <em>Toda</em> (Pricking pain), <em>Sangharsha</em> (foreign body sensation), <em>Achchasruta</em> (watery discharge), <em>Alpa</em> <em>Shopha</em> (mild chemosis), <em>Vishushka</em> <em>Bhava</em> (feeling of dryness), <em>Parushya</em> (roughness) etc which are very similar to the most of signs and symptoms of the Allergic Conjunctivitis. It is one of the most common type of eye allergy and is widely experienced by global population. Aims and Objective: . To evaluate and compare the efficacy of <em>Punarnavadi</em> eye drops and <em>Gutika Anjana</em> in the management of <em>Vataja Abhishyanda</em>(Allergic conjunctivitis). Materials and methods: Total 104 patients diagnosed with symptoms and signs of<em> Vataja</em> <em>Abhishyanda</em> were selected from the outpatient department of <em>Shalakya</em> <em>tantra</em>. The selected patients were assigned randomly into two groups, group A (<em>Punarnavadi</em> eye drop) having 51 and group B (<em>Gutika</em> <em>Anjana</em>) having 50 patients. Duration of treatment was 8weeks with follow up for one month after the trial. Result: In Group A, 96.08% got complete relief after the completion of treatment, 03.92% got marked improvement. In Group B, 98% got complete relief after the completion of treatment, 2% got marked improvement. Conclusion: <em>Gutika Anjana</em> shows better relief in all sign and symptoms on the basis of percentage. The reason may be <em>Anjana </em>has maximum absorption due to more contact of time with the tissue which is responsible for better bioavailability.</p> ER -